Compare, Analyse Biocon with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 BIOCON    MYLAN
EQUITY SHARE DATA
    BIOCON
Mar-21
MYLAN
Dec-18
BIOCON /
MYLAN
5-Yr Chart
Click to enlarge
High Rs4883,544-   
Low Rs2751,951-   
Sales per share (Unadj.) Rs59.21,630.7-  
Earnings per share (Unadj.) Rs7.744.3-  
Cash flow per share (Unadj.) Rs13.7349.6-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs62.31,764.1-  
Shares outstanding (eoy) m1,200.00514.50-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x6.41.7 382.0%   
Avg P/E ratio x49.462.0 79.7%  
P/CF ratio (eoy) x27.97.9 354.8%  
Price / Book Value ratio x6.11.6 393.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m457,3501,413,437 32.4%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m17,4100-   
Avg. sales/employee Rs ThNM23,970.8-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM650.9-  
INCOME DATA
Net Sales Rs m71,058838,977 8.5%  
Other income Rs m6,0520-   
Total revenues Rs m77,110838,977 9.2%   
Gross profit Rs m13,145217,096 6.1%  
Depreciation Rs m7,151157,090 4.6%   
Interest Rs m57740,352 1.4%   
Profit before tax Rs m11,46919,655 58.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,215-3,127 -70.8%   
Profit after tax Rs m9,25422,782 40.6%  
Gross profit margin %18.525.9 71.5%  
Effective tax rate %19.3-15.9 -121.4%   
Net profit margin %13.02.7 479.6%  
BALANCE SHEET DATA
Current assets Rs m76,004468,484 16.2%   
Current liabilities Rs m42,101341,577 12.3%   
Net working cap to sales %47.715.1 315.4%  
Current ratio x1.81.4 131.6%  
Inventory Days Days13784 163.4%  
Debtors Days Days6393 67.0%  
Net fixed assets Rs m106,142162,748 65.2%   
Share capital Rs m6,000447 1,343.2%   
"Free" reserves Rs m68,7280-   
Net worth Rs m74,728907,620 8.2%   
Long term debt Rs m29,616979,613 3.0%   
Total assets Rs m182,1462,434,589 7.5%  
Interest coverage x20.91.5 1,403.9%   
Debt to equity ratio x0.41.1 36.7%  
Sales to assets ratio x0.40.3 113.2%   
Return on assets %5.42.6 208.1%  
Return on equity %12.42.5 493.4%  
Return on capital %11.53.2 363.1%  
Exports to sales %00-   
Imports to sales %7.20-   
Net fx Rs m6,7070-   
CASH FLOW
From Operations Rs m11,597174,340 6.7%  
From Investments Rs m-36,247-90,114 40.2%  
From Financial Activity Rs m25,640-81,218 -31.6%  
Net Cashflow Rs m7231,444 50.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 74.45 Rs / USD

Compare BIOCON With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare BIOCON With: MOREPEN LABS  INDOCO REMEDIES  CONCORD DRUGS  KOPRAN.  STRIDES PHARMA SCIENCE  



Today's Market

Sensex Ends 139 Points Higher; ICICI Bank, Wipro and ITC Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views On News

BIOCON Announces Quarterly Results (4QFY21); Net Profit Up 118.6% (Quarterly Result Update)

Jul 8, 2021 | Updated on Jul 8, 2021

For the quarter ended March 2021, BIOCON has posted a net profit of Rs 4 bn (up 118.6% YoY). Sales on the other hand came in at Rs 18 bn (up 16.3% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (3QFY21); Net Profit Down 19.7% (Quarterly Result Update)

Jan 25, 2021 | Updated on Jan 25, 2021

For the quarter ended December 2020, BIOCON has posted a net profit of Rs 2 bn (down 19.7% YoY). Sales on the other hand came in at Rs 19 bn (up 5.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

Why Did Pharma Stocks Surge? (Views On News)

Jul 17, 2021

A look into the factors contributing to the rally in pharma stocks.

Bajaj Healthcare Rallies 11% on DRDO Nod to Manufacture Oral Covid Drug (Views On News)

Jul 8, 2021

Bajaj Healthcare has more than doubled investors' wealth in the year 2021 so far. The counter has delivered over 240% return in the last one year.

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

More Views on News

Most Popular

A 25 Bagger Indian Stock at the Centre of the Global Semiconductor Chip Shortage (Profit Hunter)

Jul 13, 2021

One technology company in India is grossly underrated despite its dominant role in semiconductor chip designing.

RBI Opens a New Market for Investors (Fast Profits Daily)

Jul 16, 2021

You now have a new way to create wealth. Grab it with both hands.

OPEC is Dying! RIP OPEC (Fast Profits Daily)

Jul 13, 2021

Why the global oil cartel is unravelling and how India stands to gain.

A Better Way than the Zomato IPO to Play the Food Delivery Megatrend (Profit Hunter)

Jul 14, 2021

A unique backdoor way of making big profits from smallcap companies.

Top 3 Risks for the Nifty Today (Fast Profits Daily)

Jul 12, 2021

Don't ignore the risks to the Nifty that are hiding in plain sight.

More
-->

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

BIOCON SHARE PRICE


Jul 23, 2021 (Close)

TRACK BIOCON

MORE ON BIOCON

BIOCON - BAL PHARMA COMPARISON

COMPARE BIOCON WITH

FEATURED VIDEOS

What is the Best Time to Sell a Stock?

What Will Make You Rich Faster: Investing or Trading?

CRISIL v/s CARE Ratings: An Interesting Comparison

The 3-Word Secret to Earning Incredible Returns

More Featured Videos

MARKET STATS